dimm slots
Florida lawmaker's party switch increases Republican supermajority in the House
Arizona State, Iowa State front-runners in what could be wild Big 12 finishIf you’re sitting on a pile of travel or credit card rewards with no immediate travel plans, donating them to a charity is an easy way to have a positive impact. And it's a popular way to give: In 2021, Alaska Airlines Mileage Plan members donated around 94 million miles to charities at an approximate cash value of $2.6 million, according to the airline. Beyond the social benefits, miles donations also qualify as activity on your loyalty account and can prevent the rest of your rewards from expiring . But if you’re in the habit of maximizing points and miles, you might also want to stretch the value of your charitable donations as far as possible. And by that measure, some methods of donating points and miles fall short. Here’s what to consider before donating your miles and points . Many loyalty programs make it easy to redeem your points and miles for a donation directly through their rewards portals. But some portals — especially those from airline and hotel programs — don’t publish the cash value a charity will receive for your miles or points. That means the charity may receive less value for your donation than you’d think, while also making it hard to compare the value of a donation with the value of other options for redeeming your points. Best Western Rewards is one of the few loyalty programs that publishes a cash value for charitable points donations. The charity will receive $2 for every 500 points you donate, for a point a value of 0.4 cent each. NerdWallet values Best Western points at 0.6 cent apiece, so you would receive 33% less value for your donation relative to using them for a hotel stay. Generally, the Internal Revenue Service (IRS) doesn’t count points and miles as a source of income, so if you donate them, you can't deduct the cash value of your gift. This lack of favorable tax treatment for the consumer combined with the uncertain value you’ll often receive for miles and points donations should have you at least consider other avenues for your philanthropic endeavors. Keep in mind that this drawback only matters for taxpayers who itemize deductions on their income tax returns. If you're like most people and take the standard deduction instead of itemizing, you wouldn't be able to get a charitable tax deduction from any donation. Some rewards programs have a minimum donation amount for select charities. For example, you’d have to donate at least 2,000 Southwest Rapid Rewards points for a donation to the Make-A-Wish Foundation. That minimum amount makes it tougher to donate points that may be collecting dust in your loyalty account. To maximize the value of your donation, consider a charity that books travel directly with your miles or points rather than donating directly through your loyalty program's portal. For example, Miles4Migrants uses donated airline miles and credit card points to directly book award travel for refugees and asylum seekers. “Instead of maximizing points and miles to book a dream trip, we do it to help refugees reach safe new beginnings,” said Patrick Stouffer, partnerships manager at Miles4Migrants, in an email. Miles4Migrants has redeemed over 775 million donated miles in pursuit of their mission, with a cash value of over $17 million. That expertise allows them to get more value out of every donation. “Our team has the specialized knowledge necessary to stretch the value of every point or mile, ensuring donations go as far as possible,” Stouffer said. “Even if you aren’t able to reap any tax advantages of donating your points, at least you’ll know they made the largest possible impact.” Direct cash donations help avoid the downsides of donating miles and points. If you have a credit card that earns cash back , or if you earn cash rewards through a shopping portal like TopCashBack or Rakuten , consider cashing out and donating those rewards instead of your miles and points. With a cash donation, you’ll know the exact value a charity will receive from your donation and likely qualify for a potential itemized deduction on your taxes. Some rewards programs make this process simple and transparent. Travel rewards programs sometimes incentivize charitable giving by offering bonus points for your cash donations. For example, American Airlines offers 10 AAdvantage miles for every dollar members contribute to the charity Stand Up To Cancer. That extra incentive can be an individual boon for your charitable donation. Just be aware that any points or miles you receive from such promotions will reduce the tax deductibility of your contribution. American Airlines values those bonus miles you receive through donations at 3 cents each. So if you donate $100 and receive 1,000 AAdvantage miles, American values those miles at $30. You’ll receive a tax form declaring those rewards as $30 in income, giving you a qualifying tax deduction of $70. When you donate cash and receive bonus points, the charity still receives your full donation and you get a slug of points. While you'll have to pay taxes on those points, it can still be a big win for your future travel plans. More From NerdWallet Need Credit Card Debt Relief? Debt Management Could Help If You’re in Credit Card Debt, Forget About Rewards How to Go Cashless While Also Avoiding Credit Card Debt Craig Joseph writes for NerdWallet. Email: cjoseph@nerdwallet.com . The article Should You Donate Your Points and Miles to Charity? originally appeared on NerdWallet.
Idaho execution costs, challenges persist as state’s $100,000 lethal injection drugs expire
VALPARAISO, Ind. (AP) — Valparaiso hired longtime Marietta coach Andy Waddle as its new football coach, athletic director Laurel Hosmer announced Monday. Read this article for free: Already have an account? To continue reading, please subscribe: * VALPARAISO, Ind. (AP) — Valparaiso hired longtime Marietta coach Andy Waddle as its new football coach, athletic director Laurel Hosmer announced Monday. Read unlimited articles for free today: Already have an account? VALPARAISO, Ind. (AP) — Valparaiso hired longtime Marietta coach Andy Waddle as its new football coach, athletic director Laurel Hosmer announced Monday. Waddle is scheduled to be formally introduced on campus Wednesday. He spent the last 12 seasons turning around the Division III program located in Southeastern Ohio. There, he went 55-61 after inheriting a winless team. He led the Pioneers to their first 8-0 start last season and matched the 1920 squad’s school record with a 13-game winning streak that started in 2023. In 2024, Marietta made its first postseason appearance since 1973. Waddle went 16-5 over the past two seasons and produced seven winning records over the last eight seasons. The Pioneers had only two winning seasons in the previous 20 years. “I think there is a great group of young men on the (Valparaiso) roster, and we’re excited to invest in those student-athletes and continue to add more high-quality people and football players to the program,” Waddle said of the program located in Indiana’s northwest corner. “I think Valpo is not only an outstanding fit for me professionally, but also an outstanding fit for me and my family.” Waddle spent eight seasons working with the defense as an assistant for his alma mater, Wittenberg, where he was an all-conference defensive back. He also has coached at Mansfield University in Pennsylvania and at Maryville College in Tennessee. “His experience building success and winning culture as a head coach, passion for developing student-athletes on and off the field and high character made it clear he was the right leader for our football program,” Hosmer said in a statement. The move comes two weeks after Hosmer announced the school would not give Landon Fox a contract extension after his deal expired. Fox was 21-42 in six seasons at Valparaiso. ___ Get poll alerts and updates on the AP Top 25 throughout the season. Sign up here. AP college football: https://apnews.com/hub/ap-top-25-college-football-poll and https://apnews.com/hub/college-football AdvertisementUS Steel shares drop after Biden plans to block Nippon Steel deal - BloombergBanque Cantonale Vaudoise Cuts Holdings in Global X Future Analytics Tech ETF (NASDAQ:AIQ)
SAINT CHARLES, Mo. (AP) — Jaylon McDaniel's 22 points helped Lindenwood defeat IU Indianapolis 81-63 on Saturday night. McDaniel shot 9 of 12 from the field and 4 of 6 from the free-throw line for the Lions (5-6). Markeith Browning II scored 18 points while going 8 of 19 (1 for 3 from 3-point range) and added seven rebounds, five assists, and three steals. Reggie Bass shot 3 for 6 (2 for 5 from 3-point range) and 6 of 7 from the free-throw line to finish with 14 points, while adding seven rebounds and six assists. Paul Zilinskas finished with 18 points for the Jaguars (5-8). IU Indianapolis also got 13 points and two steals from Jarvis Walker. Alec Millender also recorded 11 points and five assists. NEXT UP Lindenwood's next game is Thursday against Tennessee Tech at home, and IU Indianapolis visits Florida International on Saturday. The Associated Press created this story using technology provided by Data Skrive and data from Sportradar .None
Ivana Bacik had separate meetings with Fianna Fail leader Micheal Martin and Fine Gael leader Simon Harris on Tuesday afternoon. Fianna Fail, which won 48 seats in last month’s general election, and Fine Gael, which secured 38 seats, headed up the last coalition in Dublin and are expected to continue that partnership into the next mandate. However, with a combined 86 seats, they are just short of the 88 required for a majority in the Dail parliament. If they wish to return to government together, they would need one smaller party as a junior partner, or a handful of independents. Both Fianna Fail and Fine Gael have ruled out doing business with Sinn Fein, which won 39 seats. The centre-left Social Democrats and Irish Labour Party, both of which won 11 seats in the election, are seen as the only two realistic options if Fianna Fail and Fine Gael seek to convince a smaller party to join the coalition. In a statement, the Labour Party said Ms Bacik outlined key policy priorities in her meetings with Taoiseach Mr Harris and Tanaiste Mr Martin. “There was discussion in both meetings on policies and manifesto commitments on housing, health, climate, workers’ rights and disability services among other issues,” said the statement. “The parliamentary party will meet at 1pm on Friday where the party leader will provide an assessment of engagement to date and consider the outcome of these meetings.” A spokesman for Mr Harris said there had been a “constructive engagement” with Ms Bacik. “The Taoiseach is grateful for the time and engagement on a range of substantial policy issues,” he said. The spokesman said Mr Harris had also met independent TDs who are aligned together in what is called the regional group. “These meetings have been productive,” he added. Mr Harris and party colleagues are due to meet the Social Democrats on Wednesday. Fianna Fail deputy leader Jack Chambers and Fine Gael deputy leader Helen McEntee met on Tuesday evening for discussions on government formation, with the parties’ full negotiating teams set to meet on Wednesday. Fine Gael said the meeting between Ms McEntee and Mr Chambers was “positive” and focused on the “structure and format” of the substantive negotiations going forward. When the two parties entered coalition for the first time after the last general election in 2020, there was only a three-seat difference in their relative strength. That resulted in an equal partnership at the head of the coalition, with the Green Party as the junior partner. The two main parties swapped the role of taoiseach halfway through the term. With Fianna Fail’s lead over Fine Gael having grown to 10 seats following this election, focus has turned to the future of the rotating taoiseach arrangement and whether it will operate again in the next mandate and, if so, on what basis. There are similar questions around the distribution of ministries and other roles. While Mr Martin has so far refused to be drawn on the specifics, he has suggested that he expects Fianna Fail’s greater strength of numbers to be reflected in the new administration. However, Mr Harris has insisted that Fine Gael’s mandate cannot be taken for granted when it comes to government formation. Richard Boyd Barrett from People Before Profit-Solidarity, which won three seats, urged Labour not to “prop up” up a Fianna Fail/Fine Gael administration. “We think that’s a huge mistake,” he told reporters in Dublin. “They shouldn’t do it. They should learn the lessons of the past and actually work with other parties of the left to form a decent left opposition to Fianna Fail and Fine Gael and campaign on the issues that matter.” His party colleague Paul Murphy pointed to the experience of the Green Party, which lost all but one of its 12 seats in the election. “In reality, what is going to happen is a changing of the mudguard for Fianna Fail and Fine Gael,” he said. “And for those who are now auditioning to be a new mudguard for Fianna Fail and Fine Gael, there is a very, very sharp and stark lesson in what happened to the Green Party – obviously almost entirely wiped out. “We think it is a very major mistake for anyone who has the perception of being left, with the votes of people who are looking left, to seek to go into coalition with Fianna Fail and Fine Gael.”
Judge rejects request to sideline SJSU volleyball player
NEW DELHI (Reuters): Indian Prime Minister Narendra Modi’s party and its allies were set to return to power in the nation’s richest state, television channels reported on Saturday, a boost for the Hindu-nationalist leader after a disappointing general election. In Maharashtra, home to India’s financial capital Mumbai, the Bharatiya Janata Party-led Mahayuti alliance was leading in 221 of 288 seats. The opposition Congress party and its allies are leading in 55 seats in the state elections, local media reported. “The Mahayuti government [...] has achieved undisputed and resounding success,” Eknath Shinde, the state’s chief minister, said on social media platform X. Modi lost his majority in parliamentary elections held between April and June and had to depend on fickle allies to form a government. Last month his party won state elections in the northern state of Haryana. State election wins help political parties boost their numbers in the upper house of parliament, which is key for decision-making. In the mine-rich eastern Jharkhand state, the ruling regional party Jharkhand Mukti Morcha, which is in alliance with the Congress-led opposition, is leading to regain control by defeating the BJP and its allies, media reported. Political parties in both states have rolled out a range of measures that they say will benefit farmers and women, both considered critical voting blocks. Results from Maharashtra and Jharkhand are expected later on Saturday.
MIAMI, Nov. 25, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. NSPR , developer of the CGuardTM Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced the appointment of accomplished medical technology executive Scott R. Ward to its Board of Directors. Mr. Ward most recently served as Chief Executive Officer and President of Cardiovascular Systems, Inc. prior to its acquisition by Abbott ABT in April 2023. Paul Stuka, Chairman of the Board of InspireMD, stated, "We are extremely fortunate to add Scott to what I consider to be a world-class Board of Directors. With his extensive operational experience and track record in the cardiovascular space, his insights will be invaluable as the Company rapidly approaches potential U.S. approval of CGuard Prime, the most significant value inflection point in its history. I look forward to Scott's contributions and believe he will have an immediate impact." Marvin Slosman, Chief Executive Officer of InspireMD and Board member, commented, "The addition of Scott to our Board adds tremendous experience in the cardiovascular field, with a track record of growth and innovation as an executive, a board member and investor. His experience and legacy in the space will help guide us through our next stages of advancing our novel carotid platform as part of a comprehensive approach to catalyzing on the market shift toward a stent first standard while also guiding our pipeline of innovation, including our CAS, TCAR and Neuro focus." "I am very excited to join the InspireMD Board at such a transformational time for the company," added Mr. Ward. "With an impressive body of data demonstrating the superior short- and long-term patient outcomes of its novel CGuard Prime carotid stent system, I believe that CGuard, when approved in the U.S., will quickly become a new standard-of-care for carotid intervention and stroke prevention. I look forward to working with my fellow Board members and the InspireMD leadership team to achieve this goal." Mr. Ward has over 40 years of experience in the healthcare industry, including nearly 30 years at Medtronic, Inc. where he served in various leadership roles including as Senior Vice President and President of the CardioVascular, Neurological and Diabetes businesses. Mr. Ward is the Founder of Raymond Holdings, a firm with activities in venture capital, strategy and transactional advisory services for medical technology and life science companies. He earned his Bachelor of Science in Genetics and Cell Biology, his Master of Science in Toxicology, and his Master of Business Administration, all from the University of Minnesota. About InspireMD, Inc. InspireMD seeks to utilize its proprietary MicroNet ® technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD's common stock is quoted on the Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on our website. For more information, please visit www.inspiremd.com . Forward-looking Statements This press release contains "forward-looking statements." Forward-looking statements include, but are not limited to, statements regarding InspireMD or its management team's expectations, hopes, beliefs, intentions or strategies regarding the future. Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential", "scheduled" or similar words. Forward-looking statements include, but are not limited to, statements regarding InspireMD or its management team's or directors' expectations, hopes, beliefs, intentions or strategies regarding future events, future financial performance, strategies, expectations, competitive environment and regulation, including potential U.S. commercial launch.. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the company's control, and cannot be predicted or quantified and consequently; actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with our history of recurring losses and negative cash flows from operating activities, significant future commitments and the uncertainty regarding the adequacy of our liquidity to pursue our complete business objectives, and substantial doubt regarding our ability to continue as a going concern; our need to raise additional capital to meet our business requirements in the future and such capital raising may be costly or difficult to obtain and could dilute our stockholders' ownership interests; market acceptance of our products; an inability to secure and maintain regulatory approvals for the sale of our products; negative clinical trial results or lengthy product delays in key markets; our ability to maintain compliance with the Nasdaq listing standards; our ability to generate revenues from our products and obtain and maintain regulatory approvals for our products; our ability to adequately protect our intellectual property; our dependence on a single manufacturing facility and our ability to comply with stringent manufacturing quality standards and to increase production as necessary; the risk that the data collected from our current and planned clinical trials may not be sufficient to demonstrate that our technology is an attractive alternative to other procedures and products; intense competition in our industry, with competitors having substantially greater financial, technological, research and development, regulatory and clinical, manufacturing, marketing and sales, distribution and personnel resources than we do; entry of new competitors and products and potential technological obsolescence of our products; inability to carry out research, development and commercialization plans; loss of a key customer or supplier; technical problems with our research and products and potential product liability claims; product malfunctions; price increases for supplies and components; insufficient or inadequate reimbursement by governmental and other third-party payers for our products; our efforts to successfully obtain and maintain intellectual property protection covering our products, which may not be successful; adverse federal, state and local government regulation, in the United States, Europe or Israel and other foreign jurisdictions; the fact that we conduct business in multiple foreign jurisdictions, exposing us to foreign currency exchange rate fluctuations, logistical and communications challenges, burdens and costs of compliance with foreign laws and political and economic instability in each jurisdiction; the escalation of hostilities in Israel, which could impair our ability to manufacture our products; and current or future unfavorable economic and market conditions and adverse developments with respect to financial institutions and associated liquidity risk. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC's web site at http://www.sec.gov . The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise. Investor Contacts: Craig Shore Chief Financial Officer InspireMD, Inc. 888-776-6804 craigs@inspiremd.com Chuck Padala, Managing Director LifeSci Advisors 646-627-8390 chuck@lifesciadvisors.com investor-relations@inspiremd.com © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.Percentages: FG .418, FT .750. 3-Point Goals: 10-26, .385 (Butler 5-9, Campbell 2-3, Khayat 1-2, M.Johnson 1-4, Thomas 1-7, Exacte 0-1). Team Rebounds: 3. Team Turnovers: 1. Blocked Shots: 1 (Towns). Turnovers: 10 (Campbell 4, M.Johnson 3, Butler, Felt, Towns). Steals: 6 (Campbell 2, Green, Khayat, M.Johnson, Thomas). Technical Fouls: None. Percentages: FG .500, FT .909. 3-Point Goals: 8-20, .400 (Karasinski 2-4, Smith 2-4, B.Johnson 2-6, Hopf 1-1, Branson 1-2, Goodin 0-1, Hacker 0-2). Team Rebounds: 1. Team Turnovers: 1. Blocked Shots: 4 (Branson 2, Hacker 2). Turnovers: 9 (Branson 2, Hopf 2, B.Johnson, Hacker, Karasinski, Smith, Whitaker). Steals: 6 (Smith 3, Doyle, Hopf, Karasinski). Technical Fouls: None. .